Clinical Trials in Arcadia, United States
Locations / Arcadia, United States
Delta Trials records 236 clinical trials conducted in Arcadia, United States, making it a notable site of clinical research activity. These trials across 349 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 34 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Arcadia has changed over time.
236
Total Trials
349
Conditions
34
Terminated since 2020
Browse by condition (349 total)
- All Unspecified childhood solid tumor, protocol specific trials
- All Recurrent childhood acute lymphoblastic leukemia trials
- Recurrent neuroblastoma 12 trialsAll Recurrent neuroblastoma trials
- Diabetic macular edema 12 trialsAll Diabetic macular edema trials
- All Neovascular age-related macular degeneration trials
- Major depressive disorder 11 trialsAll Major depressive disorder trials
- Recurrent childhood rhabdomyosarcoma 9 trialsAll Recurrent childhood rhabdomyosarcoma trials
- All Recurrent childhood lymphoblastic lymphoma trials
- All Recurrent childhood cerebellar astrocytoma trials
- All Recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor trials
- Recurrent osteosarcoma 8 trialsAll Recurrent osteosarcoma trials
- Recurrent childhood medulloblastoma 8 trialsAll Recurrent childhood medulloblastoma trials
- All Recurrent childhood large cell lymphoma trials
- All Recurrent childhood cerebral astrocytoma trials
- All Recurrent childhood small noncleaved cell lymphoma trials
- All Recurrent childhood acute myeloid leukemia trials
- Recurrent childhood ependymoma 7 trialsAll Recurrent childhood ependymoma trials
- All Previously treated childhood rhabdomyosarcoma trials
- All Childhood chronic myelogenous leukemia trials
- All Recurrent wilms tumor and other childhood kidney tumors trials